Net Loss of Norris Medicines reported to Rs 0.31 crore in the quarter ended June 2025 as against net loss of Rs 0.37 crore during the previous quarter ended June 2024. Sales rose 102.78% to Rs 1.46 crore in the quarter ended June 2025 as against Rs 0.72 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
| Sales | 1.46 | 0.72 | 103 |
| OPM % | -6.85 | -23.61 | - |
| PBDT | -0.19 | -0.24 | 21 |
| PBT | -0.31 | -0.37 | 16 |
| NP | -0.31 | -0.37 | 16 |